Therapeutics News and Research

RSS

Malaria protein discovery opens new avenues for combating deadly infection

The discovery of a malaria protein that helps the parasite grow inside red blood cells and plays a key regulatory role in the parasite's immune evasion tactics could pave the way for new vaccines or therapeutics to combat the deadly infection.

26 Oct 2023

City of Hope, TGen receive $4.5 million to validate liquid biopsy for early detection of pancreatic cancer

City of Hope, one of the largest cancer research and treatment organizations in the United States, and TGen are leading an international group that has been awarded $4.5 million to validate a liquid biopsy for the early detection of pancreatic cancer.

26 Oct 2023

UCD professor wins ERC Synergy grant to unlock the secrets to healthy aging

Do bats hold the secret to health and longevity? A team led by Professor Emma Teeling, Full Professor of Zoology at University College Dublin (UCD), has won a prestigious European Research Council (ERC) Synergy grant of almost €12 million, to explore this fascinating question.

26 Oct 2023

Clinical trial launched to explore new drug treatments for military personnel and veterans with PTSD

A groundbreaking clinical trial launched October 16 will explore the promise of new drug treatments for military personnel and veterans suffering from post-traumatic stress disorder (PTSD).

26 Oct 2023

Researchers receive €10.6 million to develop new therapeutic approaches to target glioblastoma

Researchers at the Universities of Amsterdam and Leiden together with the Netherlands Cancer Institute (Amsterdam) and Oncode Institute (Utrecht) have received a €10.6 million ERC Synergy Grant to develop innovative therapeutic approaches to target glioblastoma, a deadly primary brain tumor for which no curing therapy is yet available.

26 Oct 2023

Stanford chemists uncover new pathway for protein degradation, opening door to new therapeutics

When targeting problem proteins involved in causing or spreading disease, a drug will often clog up a protein's active site so it can't function and wreak havoc.

25 Oct 2023

AI tool effectively detects distress in hospital workers' conversations

An artificial intelligence tool effectively detected distress in hospital workers' conversations with their therapists early in the pandemic, a new study shows, suggesting a potential new technology that screens for depression and anxiety.

24 Oct 2023

Perioperative durvalumab may change standard-of-care for patients with resectable lung cancer

A regimen of pre-surgical immunotherapy and chemotherapy followed by post-surgical immunotherapy significantly improved event-free survival (EFS) and pathologic complete response (pCR) rates compared to chemotherapy alone for patients with operable non-small cell lung cancer (NSCLC), according to results of a Phase III trial reported by researchers at The University of Texas MD Anderson Cancer Center.

24 Oct 2023

University of Cincinnati Cancer Center receives Institutional Research Grant from American Cancer Society

The American Cancer Society has awarded the University of Cincinnati Cancer Center an Institutional Research Grant.

24 Oct 2023

New "pseudo cell" formulation could revolutionize treatment of vitreoretinal diseases

Researchers from the Institute of Process Engineering (IPE) of the Chinese Academy of Sciences and Beijing Chaoyang Hospital have developed a new "pseudo cell" formulation based on self-healing microcapsule-loading exosomes to treat diverse vitreoretinal diseases.

24 Oct 2023

University of Montana awarded $12.3 million contract to develop novel vaccine adjuvant for TB vaccine

The National Institutes of Health recently awarded a $12.3 million contract to the University of Montana to develop a novel vaccine adjuvant for use in a tuberculosis vaccine. Adjuvants are substances that boost the effectiveness of vaccines.

24 Oct 2023

Novel GLP-1 receptor agonists offer hope for long-lasting diabetes treatment

In a study published in Scientific Reports, researchers engineer long-lasting GLP-1 receptor agonists by fusing GLP-1 with an HSA-binding protein. These chimeric molecules show promise for the treatment of type 2 diabetes due to their stability, functionality, and high affinity for the GLP-1 receptor and human serum albumin.

22 Oct 2023

Study reveals how tuberculosis bacteria form cords to resist antibiotics

The ability of Mycobacterium tuberculosis (MTB), a serious respiratory infection, to form snake-like cords was first noted nearly 80 years ago. In a study published October 20 in the journal Cell, investigators report the biophysical mechanisms by which these cords form and demonstrate how several generations of dividing bacteria hang together to create these structures that enable resistance to antibiotics.

20 Oct 2023

Pioneering partnership supports early-stage innovation against antimicrobial resistance to save lives

Innovate UK, LifeArc, and Medicines Discovery Catapult (MDC) have joined forces to create PACE (Pathways to Antimicrobial Clinical Efficacy), a £30 million initiative supporting early-stage innovation against antimicrobial resistance (AMR) to save lives. PACE has today (19 October 2023) announced its first funding call with up to £10 million available to support innovators developing new antimicrobials.

20 Oct 2023

Experts from the research and innovation community invited to tackle anti-microbial resistance

Researchers, policy-makers and business leaders from across the research and innovation community are invited to help tackle one of humanity’s biggest threats, anti-microbial resistance (AMR).

20 Oct 2023

Clinical study evaluates safety and efficacy of methylone in patients with severe PTSD

Clerkenwell Health, the modern mental health company specializing in matching patients with cutting-edge psychiatry treatments, today announced that it is taking part in Transcend Therapeutics’ Phase 2 study evaluating the safety and efficacy of methylone in patients with severe PTSD.

20 Oct 2023

Therapeutics News and Research

Malaria protein discovery opens new avenues for combating deadly infection

City of Hope, TGen receive $4.5 million to validate liquid biopsy for early detection of pancreatic cancer

UCD professor wins ERC Synergy grant to unlock the secrets to healthy aging

Clinical trial launched to explore new drug treatments for military personnel and veterans with PTSD

Researchers receive €10.6 million to develop new therapeutic approaches to target glioblastoma

Stanford chemists uncover new pathway for protein degradation, opening door to new therapeutics

AI tool effectively detects distress in hospital workers' conversations

Perioperative durvalumab may change standard-of-care for patients with resectable lung cancer

University of Cincinnati Cancer Center receives Institutional Research Grant from American Cancer Society

New "pseudo cell" formulation could revolutionize treatment of vitreoretinal diseases

University of Montana awarded $12.3 million contract to develop novel vaccine adjuvant for TB vaccine

Novel GLP-1 receptor agonists offer hope for long-lasting diabetes treatment

Study reveals how tuberculosis bacteria form cords to resist antibiotics

Pioneering partnership supports early-stage innovation against antimicrobial resistance to save lives

Experts from the research and innovation community invited to tackle anti-microbial resistance

Clinical study evaluates safety and efficacy of methylone in patients with severe PTSD

How ketamine treatment elicits long-lasting anti-depressive effects

Study finds more mature gut microbiome in malnourished Nigerien children after antibiotic treatment

How does diet impact rosacea and acne?

How does oxidative stress during pregnancy influence the child’s behavior and emotional states?

Industry Focus eBook - Cell biology (5th edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News